Literature DB >> 29784680

Raising NAD in Heart Failure: Time to Translate?

Matthew A Walker1, Rong Tian2.   

Abstract

Entities:  

Keywords:  Editorials; NAD; heart failure; nicotinamide riboside

Mesh：

Substances：

Year:  2018        PMID： 29784680      PMCID： PMC5967641          DOI： 10.1161/CIRCULATIONAHA.117.032626

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  14 in total

Review 1.  NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus.

Authors:  Carles Cantó; Keir J Menzies; Johan Auwerx
Journal:  Cell Metab       Date:  2015-06-25       Impact factor: 27.287

Review 2.  NAD+ metabolism in health and disease.

Authors:  Peter Belenky; Katrina L Bogan; Charles Brenner
Journal:  Trends Biochem Sci       Date:  2006-12-11       Impact factor: 13.807

Review 3.  The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.

Authors:  Riekelt H Houtkooper; Carles Cantó; Ronald J Wanders; Johan Auwerx
Journal:  Endocr Rev       Date:  2009-12-09       Impact factor: 19.871

4.  Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway.

Authors:  Vinodkumar B Pillai; Nagalingam R Sundaresan; Gene Kim; Madhu Gupta; Senthilkumar B Rajamohan; Jyothish B Pillai; Sadhana Samant; P V Ravindra; Ayman Isbatan; Mahesh P Gupta
Journal:  J Biol Chem       Date:  2009-11-24       Impact factor: 5.157

5.  Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging.

Authors:  Ana P Gomes; Nathan L Price; Alvin J Y Ling; Javid J Moslehi; Magdalene K Montgomery; Luis Rajman; James P White; João S Teodoro; Christiane D Wrann; Basil P Hubbard; Evi M Mercken; Carlos M Palmeira; Rafael de Cabo; Anabela P Rolo; Nigel Turner; Eric L Bell; David A Sinclair
Journal:  Cell       Date:  2013-12-19       Impact factor: 41.582

6.  P7C3 neuroprotective chemicals function by activating the rate-limiting enzyme in NAD salvage.

Authors:  Gelin Wang; Ting Han; Deepak Nijhawan; Pano Theodoropoulos; Jacinth Naidoo; Sivaramakrishnan Yadavalli; Hamid Mirzaei; Andrew A Pieper; Joseph M Ready; Steven L McKnight
Journal:  Cell       Date:  2014-09-11       Impact factor: 41.582

7.  Normalization of NAD+ Redox Balance as a Therapy for Heart Failure.

Authors:  Chi Fung Lee; Juan D Chavez; Lorena Garcia-Menendez; Yongseon Choi; Nathan D Roe; Ying Ann Chiao; John S Edgar; Young Ah Goo; David R Goodlett; James E Bruce; Rong Tian
Journal:  Circulation       Date:  2016-08-03       Impact factor: 29.690

8.  Nicotinamide riboside is uniquely and orally bioavailable in mice and humans.

Authors:  Samuel A J Trammell; Mark S Schmidt; Benjamin J Weidemann; Philip Redpath; Frank Jaksch; Ryan W Dellinger; Zhonggang Li; E Dale Abel; Marie E Migaud; Charles Brenner
Journal:  Nat Commun       Date:  2016-10-10       Impact factor: 14.919

Review 9.  Mitochondrion as a Target for Heart Failure Therapy- Role of Protein Lysine Acetylation.

Authors:  Chi Fung Lee; Rong Tian
Journal:  Circ J       Date:  2015-08-04       Impact factor: 2.993

10.  An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers.

Authors:  Sophia E Airhart; Laura M Shireman; Linda J Risler; Gail D Anderson; G A Nagana Gowda; Daniel Raftery; Rong Tian; Danny D Shen; Kevin D O'Brien
Journal:  PLoS One       Date:  2017-12-06       Impact factor: 3.240
View more
  19 in total

Review 1.  Inflammasomes and Proteostasis Novel Molecular Mechanisms Associated With Atrial Fibrillation.

Authors:  Na Li; Bianca J J M Brundel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

2.  NAD metabolism in aging and cancer.

Authors:  John Wr Kincaid; Nathan A Berger
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-05

3.  Mitochondrial Unfolded Protein Response (UPRmt) Activation in Cardiac Diseases: Opportunities and Challenges.

Authors:  Luiz H M Bozi; Juliane C Campos; Eric R Gross; Julio C B Ferreira
Journal:  J Am Coll Cardiol       Date:  2019-08-20       Impact factor: 24.094

Review 4.  Mitochondrial complex I deficiency and cardiovascular diseases: current evidence and future directions.

Authors:  Maurizio Forte; Silvia Palmerio; Franca Bianchi; Massimo Volpe; Speranza Rubattu
Journal:  J Mol Med (Berl)       Date:  2019-03-12       Impact factor: 4.599

Review 5.  Regulation of NAD+ metabolism in aging and disease.

Authors:  Xiaogang Chu; Raghavan Pillai Raju
Journal:  Metabolism       Date:  2021-10-28       Impact factor: 8.694

Review 6.  NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential.

Authors:  Na Xie; Lu Zhang; Wei Gao; Canhua Huang; Peter Ernst Huber; Xiaobo Zhou; Changlong Li; Guobo Shen; Bingwen Zou
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

7.  Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure.

Authors:  Bo Zhou; Dennis Ding-Hwa Wang; Yanhua Qiu; Sophia Airhart; Yaxin Liu; April Stempien-Otero; Kevin D O'Brien; Rong Tian
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

Review 8.  Cardiac Energy Metabolism in Heart Failure.

Authors:  Gary D Lopaschuk; Qutuba G Karwi; Rong Tian; Adam R Wende; E Dale Abel
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

9.  Atrial fibrillation.

Authors: 
Journal:  Nat Rev Dis Primers       Date:  2016-03-31       Impact factor: 65.038

10.  Mechanisms underlying neonate-specific metabolic effects of volatile anesthetics.

Authors:  Julia Stokes; Arielle Freed; Rebecca Bornstein; Kevin N Su; John Snell; Amanda Pan; Grace X Sun; Kyung Yeon Park; Sangwook Jung; Hailey Worstman; Brittany M Johnson; Philip G Morgan; Margaret M Sedensky; Simon C Johnson
Journal:  Elife       Date:  2021-07-13       Impact factor: 8.140
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.